The annualized dividend paid by AbbVie is $6.56/share, currently paid in quarterly installments, and its most recent dividend ...

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

The report noted a strong quarterly dividend history at AbbVie Inc, and favorable long-term multi-year growth rates in key fundamental data points. The annualized dividend paid by AbbVie Inc is $6 ...

The dividend is significant to AbbVie: The company is a Dividend King, with a decades-long history of yearly increases from when it was still part of Abbott Labs. Investors can probably expect mid ...

James analyst Gary Nachman maintained an Outperform rating on AbbVie stock (NYSE:ABBV) with a $218.00 price target. The ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

AbbVie is a leader in the pharmaceutical ... The company has a great history of raising its dividend by more than 10% each year while offering a respectable yield. Procter & Gamble has a long ...

As of 22 January at 9:43:27 am GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

AbbVie (ABBV) is expected to beat Q4 earnings estimates with strong performance from key products, including Skyrizi and ...

Buying $100 In ABBV: If an investor had bought $100 of ABBV stock 5 years ago, it would be worth $213.43 today based on a ...